Essentials of SGLT2 Inhibitors in Diabetes:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cham
Adis
2017
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Beschreibung: | 1 Online Ressource (XI, 68 p. 13 illus. in color) |
| ISBN: | 9783319432960 |
| DOI: | 10.1007/978-3-319-43296-0 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043934297 | ||
| 003 | DE-604 | ||
| 005 | 20170421 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161205s2017 |||| o||u| ||||||eng d | ||
| 020 | |a 9783319432960 |c Online |9 978-3-319-43296-0 | ||
| 024 | 7 | |a 10.1007/978-3-319-43296-0 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-319-43296-0 | ||
| 035 | |a (OCoLC)965679975 | ||
| 035 | |a (DE-599)BVBBV043934297 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.46 |2 23 | |
| 082 | 0 | |a 616.462 |2 23 | |
| 084 | |a XI 4900 |0 (DE-625)153009:12905 |2 rvk | ||
| 084 | |a YC 6800 |0 (DE-625)153250:12905 |2 rvk | ||
| 100 | 1 | |a Fisher, Miles |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Essentials of SGLT2 Inhibitors in Diabetes |c Miles Fisher, Gerard McKay |
| 264 | 1 | |a Cham |b Adis |c 2017 | |
| 300 | |a 1 Online Ressource (XI, 68 p. 13 illus. in color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 340 | |a Online-Ressource | ||
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a General practice (Medicine) | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Endocrinology | |
| 650 | 4 | |a Primary care (Medicine) | |
| 650 | 4 | |a Medicine & Public Health | |
| 650 | 4 | |a Primary Care Medicine | |
| 650 | 4 | |a General Practice / Family Medicine | |
| 650 | 4 | |a Medizin | |
| 650 | 0 | 7 | |a SGLT-2-Hemmer |0 (DE-588)1093596279 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Diabetes mellitus |0 (DE-588)4070446-4 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Diabetes mellitus |0 (DE-588)4070446-4 |D s |
| 689 | 0 | 1 | |a SGLT-2-Hemmer |0 (DE-588)1093596279 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a McKay, Gerard |e Verfasser |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-3-319-43294-6 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-319-43296-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_2017 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029343312 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-319-43296-0 |l UBR01 |p ZDB-2-SME |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176869996625920 |
|---|---|
| any_adam_object | |
| author | Fisher, Miles McKay, Gerard |
| author_facet | Fisher, Miles McKay, Gerard |
| author_role | aut aut |
| author_sort | Fisher, Miles |
| author_variant | m f mf g m gm |
| building | Verbundindex |
| bvnumber | BV043934297 |
| classification_rvk | XI 4900 YC 6800 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-319-43296-0 (OCoLC)965679975 (DE-599)BVBBV043934297 |
| dewey-full | 616.46 616.462 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.46 616.462 |
| dewey-search | 616.46 616.462 |
| dewey-sort | 3616.46 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-319-43296-0 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01996nmm a2200577zc 4500</leader><controlfield tag="001">BV043934297</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170421 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161205s2017 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783319432960</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-319-43296-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-319-43296-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-319-43296-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)965679975</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043934297</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.46</subfield><subfield code="2">23</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.462</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4900</subfield><subfield code="0">(DE-625)153009:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 6800</subfield><subfield code="0">(DE-625)153250:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fisher, Miles</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Essentials of SGLT2 Inhibitors in Diabetes</subfield><subfield code="c">Miles Fisher, Gerard McKay</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Adis</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online Ressource (XI, 68 p. 13 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="340" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General practice (Medicine)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Primary care (Medicine)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine & Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Primary Care Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General Practice / Family Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">SGLT-2-Hemmer</subfield><subfield code="0">(DE-588)1093596279</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diabetes mellitus</subfield><subfield code="0">(DE-588)4070446-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Diabetes mellitus</subfield><subfield code="0">(DE-588)4070446-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">SGLT-2-Hemmer</subfield><subfield code="0">(DE-588)1093596279</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McKay, Gerard</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-3-319-43294-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-319-43296-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2017</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029343312</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-43296-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043934297 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:39:03Z |
| institution | BVB |
| isbn | 9783319432960 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029343312 |
| oclc_num | 965679975 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online Ressource (XI, 68 p. 13 illus. in color) |
| psigel | ZDB-2-SME ZDB-2-SME_2017 |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Adis |
| record_format | marc |
| spelling | Fisher, Miles Verfasser aut Essentials of SGLT2 Inhibitors in Diabetes Miles Fisher, Gerard McKay Cham Adis 2017 1 Online Ressource (XI, 68 p. 13 illus. in color) txt rdacontent c rdamedia cr rdacarrier Online-Ressource Medicine General practice (Medicine) Diabetes Endocrinology Primary care (Medicine) Medicine & Public Health Primary Care Medicine General Practice / Family Medicine Medizin SGLT-2-Hemmer (DE-588)1093596279 gnd rswk-swf Diabetes mellitus (DE-588)4070446-4 gnd rswk-swf Diabetes mellitus (DE-588)4070446-4 s SGLT-2-Hemmer (DE-588)1093596279 s DE-604 McKay, Gerard Verfasser aut Erscheint auch als Druckausgabe 978-3-319-43294-6 https://doi.org/10.1007/978-3-319-43296-0 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Fisher, Miles McKay, Gerard Essentials of SGLT2 Inhibitors in Diabetes Medicine General practice (Medicine) Diabetes Endocrinology Primary care (Medicine) Medicine & Public Health Primary Care Medicine General Practice / Family Medicine Medizin SGLT-2-Hemmer (DE-588)1093596279 gnd Diabetes mellitus (DE-588)4070446-4 gnd |
| subject_GND | (DE-588)1093596279 (DE-588)4070446-4 |
| title | Essentials of SGLT2 Inhibitors in Diabetes |
| title_auth | Essentials of SGLT2 Inhibitors in Diabetes |
| title_exact_search | Essentials of SGLT2 Inhibitors in Diabetes |
| title_full | Essentials of SGLT2 Inhibitors in Diabetes Miles Fisher, Gerard McKay |
| title_fullStr | Essentials of SGLT2 Inhibitors in Diabetes Miles Fisher, Gerard McKay |
| title_full_unstemmed | Essentials of SGLT2 Inhibitors in Diabetes Miles Fisher, Gerard McKay |
| title_short | Essentials of SGLT2 Inhibitors in Diabetes |
| title_sort | essentials of sglt2 inhibitors in diabetes |
| topic | Medicine General practice (Medicine) Diabetes Endocrinology Primary care (Medicine) Medicine & Public Health Primary Care Medicine General Practice / Family Medicine Medizin SGLT-2-Hemmer (DE-588)1093596279 gnd Diabetes mellitus (DE-588)4070446-4 gnd |
| topic_facet | Medicine General practice (Medicine) Diabetes Endocrinology Primary care (Medicine) Medicine & Public Health Primary Care Medicine General Practice / Family Medicine Medizin SGLT-2-Hemmer Diabetes mellitus |
| url | https://doi.org/10.1007/978-3-319-43296-0 |
| work_keys_str_mv | AT fishermiles essentialsofsglt2inhibitorsindiabetes AT mckaygerard essentialsofsglt2inhibitorsindiabetes |